Pharmacy

Your Article Summary

See Latest Articles

FDA eyes behind the counter drug category with greater clinical role for pharmacists
American Medical News , 12/17/07

Elliott, V.S. - The Food and Drug Administration is contemplating the establishment of a class of medications that would be available only after counseling from a pharmacist but without a physician's prescription. Physicians widely oppose the development, arguing that it could disrupt continuity of care and put patients at risk. The FDA is considering the possibility for the fourth time since the 1970s because agency officials feel the emergence of the Internet means that consumers are more informed than ever and the time may be right to make this change in the United States

Today in Over The Counter (OTC)...keeping you current

Receive free subspecialty "5-minute updates" via email

Paracetamol for intravenous use in medium- and intensive care patients: pharmacokinetics and tolerance
European Journal of Clinical Pharmacology, 03/22/10

Serum Thromboxane B2 Compared to Five Other Platelet Function Tests for the Evaluation of Aspirin Effect in Stable Cardiovascular Disease
Heart, Lung, and Circulation, 03/16/10

Physician Practice Patterns in Acute Coronary Syndromes: An Initial Report of an Individual Quality Improvement Program
Critical Pathways in Cardiology, 03/11/10

 See all of Over The Counter (OTC)

Today in Pharmacy Management...keeping you current

Receive free subspecialty "5-minute updates" via email

Use of analgesics in intentional drug overdose presentations to hospital before and after the withdrawal of distalgesic from the Irish market
BMC Clinical Pharmacology, 03/19/10

ASHP national survey of pharmacy practice in hospital settings: Monitoring and patient education—2009
American Journal of Health-System Pharmacy, 03/18/10

Pharmacotherapeutic disparities: Racial, ethnic, and sex variations in medication treatment
American Journal of Health-System Pharmacy, 03/18/10

 See all of Pharmacy Management